Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation.

MLA

Zhang, Xuehui, et al. “Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation.” Disease Markers, May 2021, pp. 1–17. EBSCOhost, https://doi.org/10.1155/2021/5530673.

APA

Zhang, X., Huang, C., Cui, B., Pang, Y., Liang, R., & Luo, X. (2021). Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation. Disease Markers, 1–17. https://doi.org/10.1155/2021/5530673

Chicago

Zhang, Xuehui, Chaoyuan Huang, Biyu Cui, Yebin Pang, Rong Liang, and Xiaoling Luo. 2021. “Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation.” Disease Markers, May, 1–17. doi:10.1155/2021/5530673.